Experimental models of liver fibrosis

Arch Toxicol. 2016 May;90(5):1025-1048. doi: 10.1007/s00204-015-1543-4. Epub 2015 Jun 6.

Abstract

Hepatic fibrosis is a wound healing response to insults and as such affects the entire world population. In industrialized countries, the main causes of liver fibrosis include alcohol abuse, chronic hepatitis virus infection and non-alcoholic steatohepatitis. A central event in liver fibrosis is the activation of hepatic stellate cells, which is triggered by a plethora of signaling pathways. Liver fibrosis can progress into more severe stages, known as cirrhosis, when liver acini are substituted by nodules, and further to hepatocellular carcinoma. Considerable efforts are currently devoted to liver fibrosis research, not only with the goal of further elucidating the molecular mechanisms that drive this disease, but equally in view of establishing effective diagnostic and therapeutic strategies. The present paper provides a state-of-the-art overview of in vivo and in vitro models used in the field of experimental liver fibrosis research.

Keywords: Animal models; Hepatic stellate cells; In vitro models; Liver fibrosis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cells, Cultured
  • Coculture Techniques
  • Genetic Predisposition to Disease
  • Hepatic Stellate Cells / metabolism
  • Hepatic Stellate Cells / pathology*
  • Humans
  • In Vitro Techniques
  • Liver / metabolism
  • Liver / pathology*
  • Liver Cirrhosis, Experimental / genetics
  • Liver Cirrhosis, Experimental / metabolism
  • Liver Cirrhosis, Experimental / pathology*
  • Liver Cirrhosis, Experimental / therapy
  • Mice, Transgenic
  • Phenotype
  • Signal Transduction
  • Wound Healing*